EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Application of nanomaterials in biomedical imaging and cancer therapy
S Siddique, JCL Chow - Nanomaterials, 2020 - mdpi.com
Nanomaterials, such as nanoparticles, nanorods, nanosphere, nanoshells, and nanostars,
are very commonly used in biomedical imaging and cancer therapy. They make excellent …
are very commonly used in biomedical imaging and cancer therapy. They make excellent …
Clinical and biological features of neuroendocrine prostate cancer
Y Yamada, H Beltran - Current oncology reports, 2021 - Springer
Abstract Purpose of Review Neuroendocrine prostate cancer (NEPC) is an aggressive
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …
Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy
O Keinänen, K Fung, JM Brennan… - Proceedings of the …, 2020 - National Acad Sciences
Over the past decade, theranostic imaging has emerged as a powerful clinical tool in
oncology for identifying patients likely to respond to targeted therapies and for monitoring …
oncology for identifying patients likely to respond to targeted therapies and for monitoring …
Bone metastases
RE Coleman, J Brown, I Holen - Abeloff's clinical oncology, 2020 - Elsevier
Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
Background Recent advances in nanotechnology have offered new hope for cancer
detection, prevention, and treatment. Nanomedicine, a term for the application of …
detection, prevention, and treatment. Nanomedicine, a term for the application of …
[HTML][HTML] Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities
In the last decade, the use of nanotheranostics as emerging diagnostic and therapeutic tools
for various diseases, especially cancer, is held great attention. Up to date, several …
for various diseases, especially cancer, is held great attention. Up to date, several …
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
J Millul, G Bassi, J Mock, A Elsayed… - Proceedings of the …, 2021 - National Acad Sciences
We describe the development of OncoFAP, an ultra-high-affinity ligand of fibroblast
activation protein (FAP) for targeting applications with pan-tumoral potential. OncoFAP binds …
activation protein (FAP) for targeting applications with pan-tumoral potential. OncoFAP binds …
Carbon-based nanomaterials for targeted cancer nanotherapy: Recent trends and future prospects
Carbon-based nanomaterials are becoming attractive materials due to their unique
structural dimensions and promising mechanical, electrical, thermal, optical and chemical …
structural dimensions and promising mechanical, electrical, thermal, optical and chemical …
Expanding theranostic radiopharmaceuticals for tumor diagnosis and therapy
C Barca, CM Griessinger, A Faust, D Depke, M Essler… - Pharmaceuticals, 2021 - mdpi.com
Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and
molecular imaging (MI), including positron emission tomography (PET), single-photon …
molecular imaging (MI), including positron emission tomography (PET), single-photon …